Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer
- PMID: 15889211
- DOI: 10.1245/ASO.2005.08.001
Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer
Abstract
Background: The aim of this study was to evaluate the clinical and therapeutic value of digital fusion image (FI) of positron emission tomography (PET) using (18)F-fluorodeoxy glucose and computed tomography (CT) in patients who were suspected of having a local recurrence of rectal cancer.
Methods: Forty-two patients (32 men and 10 women; mean age, 61.4 years, range, 40-79 years) with a suspicion of local recurrence after curative resection of rectal cancer were prospectively recruited and underwent (18)F-fluorodeoxy glucose-PET and CT. The FI was reconstructed with a commercially available digital software program, T-B Fusion. Wilcoxon signed rank test was used to compare FI with CT alone or PET alone.
Results: FI yielded a correct diagnosis in 39 (93%) of 42 patients, whereas CT alone and PET alone did so in 33 (79%) and 37 (88%) patients, respectively. FI had better diagnostic accuracy than CT alone (P = .0138) and PET alone (P = .0156). Overall, FI altered patient management in 11 (26.2%) patients on the basis of additional information, including differentiation of the tumor from the postoperative scar in 6 patients, exact anatomical location in 3 patients, and both in 2 patients.
Conclusions: FI has a potential clinical value in the treatment of suspected local recurrence of rectal cancer.
Similar articles
-
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.Oral Oncol. 2007 Oct;43(9):887-93. doi: 10.1016/j.oraloncology.2006.10.011. Epub 2007 Jan 4. Oral Oncol. 2007. PMID: 17207656
-
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.J Craniomaxillofac Surg. 2006 Jan;34(1):9-16. doi: 10.1016/j.jcms.2005.08.001. Epub 2005 Dec 15. J Craniomaxillofac Surg. 2006. PMID: 16343913
-
Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.Q J Nucl Med Mol Imaging. 2005 Sep;49(3):259-66. Q J Nucl Med Mol Imaging. 2005. PMID: 16172572 Clinical Trial.
-
Imaging of rectal cancer.Semin Radiat Oncol. 2003 Oct;13(4):389-402. doi: 10.1016/S1053-4296(03)00049-3. Semin Radiat Oncol. 2003. PMID: 14586829 Review.
-
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.J Am Coll Surg. 2005 Dec;201(6):948-56. doi: 10.1016/j.jamcollsurg.2005.06.277. J Am Coll Surg. 2005. PMID: 16310700 Review. No abstract available.
Cited by
-
18F-FDG PET/CT Habitat Radiomics Predicts Outcome of Patients with Cervical Cancer Treated with Chemoradiotherapy.Radiol Artif Intell. 2020 Nov 4;2(6):e190218. doi: 10.1148/ryai.2020190218. eCollection 2020 Nov. Radiol Artif Intell. 2020. PMID: 33937845 Free PMC article.
-
Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1168-1182. doi: 10.1007/s00259-019-04625-9. Epub 2019 Dec 5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31807885 Free PMC article.
-
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.Int J Clin Oncol. 2006 Aug;11(4):286-96. doi: 10.1007/s10147-006-0595-0. Int J Clin Oncol. 2006. PMID: 16937302 Review.
-
Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):479-87. doi: 10.1089/cbr.2012.1382. Epub 2013 May 28. Cancer Biother Radiopharm. 2013. PMID: 23713869 Free PMC article.
-
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.Dig Dis Sci. 2006 Dec;51(12):2198-205. doi: 10.1007/s10620-006-9428-2. Epub 2006 Nov 2. Dig Dis Sci. 2006. PMID: 17080242
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical